Recommended Conferences

Cancer-Treatment and Therapeutics

New York, USA
Related Subjects
 

Vitamin D

Author(s): Dusso A, Brown A, Slatopolsky E

Abstract

The vitamin D endocrine system plays an essential role in calcium homeostasis and bone metabolism, but research during the past two decades has revealed a diverse range of biological actions that include induction of cell differentiation, inhibition of cell growth, immunomodulation, and control of other hormonal systems. Vitamin D itself is a prohormone that is metabolically converted to the active metabolite, 1,25-dihydroxyvitamin D [1,25(OH)2D]. This vitamin D hormone activates its cellular receptor (vitamin D receptor or VDR), which alters the transcription rates of target genes responsible for the biological responses. This review focuses on several recent developments that extend our understanding of the complexities of vitamin D metabolism and actions: the final step in the activation of vitamin D, conversion of 25-hydroxyvitamin D to 1,25(OH)2D in renal proximal tubules, is now known to involve facilitated uptake and intracellular delivery of the precursor to 1α-hydroxylase. Emerging evidence using mice lacking the VDR and/or 1α-hydroxylase indicates both 1,25(OH)2D3-dependent and -independent actions of the VDR as well as VDR-dependent and -independent actions of 1,25(OH)2D3. Thus the vitamin D system may involve more than a single receptor and ligand. The presence of 1α-hydroxylase in many target cells indicates autocrine/paracrine functions for 1,25(OH)2D3 in the control of cell proliferation and differentiation. This local production of 1,25(OH)2D3 is dependent on circulating precursor levels, providing a potential explanation for the association of vitamin D deficiency with various cancers and autoimmune diseases.

Similar Articles

Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women’s Health Study

Author(s): Merlino LA, Curtis J, Mikuls TR, Cerhan JR, Criswell LA, et al.

Deficiency of serum concentration of 25-hydroxyvitamin D in psoriatic patients: a case-control study

Author(s): Orgaz-Molina J, Buendía-Eisman A, Arrabal-Polo MA, Ruiz JC

Vitamin D status in patients with chronic plaque psoriasis

Author(s): Gisondi P, Rossini M, Di Cesare A, Idolazzi L, Farina S, et al.

Evaluation, treatment and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline

Author(s): Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, et al.

Immunocytochemical localization of the 1,25-dihydroxyvitamin-D3 receptor in target cells

Author(s): Clemens TL, Garrett KP, Zhou XY, Pike JW, Haussler MR, et al.

Vitamin D and autoimmune rheumatologic disorders

Author(s): Plajo CF, Lopez-Benitez JM, Miller LC

Influence of narrowband UVB phototherapy on vitamin D and folate status

Author(s): Cicarma E, Mork C, Porojnicu AC, Juzeniene A, Tam TT, et al.

The effect of narrowband UV-B treatment for psoriasis on vitamin D status during wintertime in Ireland

Author(s): Ryan C, Moran B, McKenna MJ, Murray BF, Brady J, et al.

Narrowband ultraviolet B treatment boosts serum 25-hydroxyvitamin D in patients with psoriasis on oral vitamin D supplementation

Author(s): Ala-houhala MJ, Karppinen TT, Vahavihu K, Kautiainen H, Dombrowski Y, et al.

Vitamin D status in psoriasis patients during different treatments with phototherapy

Author(s): Osmancevic A, Landin-Wilhelmsen K, Larko O, Krogstad AL

Serum levels of 25-hydroxy vitamin D in psoriatic patients

Author(s): Zuchi MF, Azevedo Pde O, Tanaka AA, Schmitt JV, Martins LE

Serum 25- OH Vitamin D Level in Psoriatic Patients and Comparison With Control Subjects

Author(s): Maleki M, Nahidi Y, Azizahari S, Meibodi NT, Hadianfar A

Vitamin D receptor polymorphism is associated with psoriasis

Author(s): Park BS, Park JS, Lee DY, Youn JI, Kim IG

Vitamin D receptor polymorphisms and diseases

Author(s): Valdivielso JM, Fernandez E